Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Pharmaceutical assistance of treatment with antibacterial drugs

Show simple item record

dc.contributor.author Eșanu, Viorica
dc.date.accessioned 2022-06-15T10:59:49Z
dc.date.available 2022-06-15T10:59:49Z
dc.date.issued 2022
dc.identifier.citation EȘANU, Viorica. Pharmaceutical assistance of treatment with antibacterial drugs. In: MedEspera: the 9th International Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2022, p. 322. en_US
dc.identifier.uri https://medespera.asr.md/en/books
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/21137
dc.description.abstract Introduction. Adverse reactions to antibacterial preparations are responsible for over 140,000 emergencies, about half of which are due to reactions to antibiotics. Aim of the study. Analysis and evaluation of antibiotic complications in hospitalized patients in 2019- 2021. Methods and materials. For the present study, the consumption of antibiotics was evaluated for a period of three years (2019–2021), in the Institute of Emergency Medicine (IMU) and in its main subdivisions, which record a higher consumption of antimicrobial drugs. Results. In Moldova, the consumption of antibiotics per 1,000 inhabitants is an intermediate one and constitutes 21 defined doses. The highest consumption is in the beta-lactam and penicillin group of 7.5 DDD, followed by other beta-lactams with 3.2 DDD, and the third place belongs to fluoroquinolones with a consumption of 2.7 DDD per 1,000 inhabitants. The consumption of antibiotics in the IMU, compared to most hospitals in European countries, and others is intermediate and is 64%. The consumption of betalactams and penicillins (ampicillinum, amoxyciline, amoxicillinum + clavulanic acid) in the IMU is about five times lower than the average in the other hospitals presented, and that of other beta-lactams (cephalosporins of generation I cefalexin, cefazoline, generation II cefuroxime, cefachlor, generation III cefotaxime, ceftazidime, ceftriaxone, cefixime, cefoperazone, cefoperazone + sulbactam, carbapemen meropenem, imipenem + cilastatin) invers, are about twice as much. In the hospital 76% of patients used antibacterial drugs from the group of macrolides and cephalosporins. One of the indicators of the quality of the rational use of antibiotics is related to the ratio of parenteral and enteral pharmaceutical forms. Thus, the rate of consumption of antibacterial drugs with enteral form increased in the IMU, in the period 2019– 2021, from 14.1% to 25.2%, and that with parenteral form decreased from 85.9 to 74, 8 or 11.1%. In most hospitals around the world, the rate of consumption of parenteral forms, compared to enteral, is about 50%. Regarding the incidence of drug side effects reporters, the majority - 85.19% of cases were reported by medical workers, 7.94% - by patients, 6.49% - pharmaceutical companies and medical representatives, and pharmacists – 0,36%. Conclusion. Pharmacists should be the most accessible healthcare providers who can help patients with the best recommendations for the use of antibiotics and the prevention of possible complications during the treatment. en_US
dc.language.iso en en_US
dc.publisher Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova, Association of Medical Students and Residents en_US
dc.relation.ispartof MedEspera: The 9th International Medical Congress for Students and Young Doctors, May 12-14, 2022, Chisinau, Republic of Moldova en_US
dc.title Pharmaceutical assistance of treatment with antibacterial drugs en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2022
    The 9th International Medical Congress for Students and Young Doctors, May 12-14, 2022

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics